![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » FDA Clears Roche CINtec Histology Test
FDA Clears Roche CINtec Histology Test
![roche.gif](https://www.fdanews.com/ext/resources/test/Device_Images/roche.gif?t=1600727553&width=430)
Roche has received FDA marketing clearance for the CINtec Histology test. The p16 biomarker test, when used in conjunction with hematoxylin & eosin (H&E) staining, helps pathologists determine which women should receive treatment for cervical pre-cancer.
The test is a part of Roche’s cervical cancer portfolio, which also includes the Cobas HPV test and the CINtec plus cytology3 test.
The clearance was based on the results from a clinical study demonstrating the effectiveness of the portfolio. — Cynthia Jessup
Upcoming Events
-
21Oct